MARK ROGERS-EVANS,GERARD GRIFFIOEN,BART DE TAEYE,KATRIEN PRINCEN,KOEN DE WITTE,EMILIE BLANCHE,HASANE RATNI
申请号:
PT15710486
公开号:
PT3119782T
申请日:
2015.03.17
申请国别(地区):
PT
年份:
2018
代理人:
摘要:
The present invention relates to a compound of formula (I) or a stereoisomer, enantiomer, racemic, or tautomer thereof, Formula (I), wherein R1, R3, R4, L1, L2, L3, L4, and n, have the same meaning as that defined in the claims and the description. The present invention also relates to compositions, in particular pharmaceuticals, comprising such compounds, and to uses of such compounds and compositions for the prevention and/or treatment of metabolic disorders and/or neurodegenerative diseases, and/or protein misfolding disorders.